IOBT
Price
$1.44
Change
-$0.07 (-4.64%)
Updated
Jun 27 closing price
Capitalization
94.87M
39 days until earnings call
RGNX
Price
$8.39
Change
-$0.36 (-4.11%)
Updated
Jun 27 closing price
Capitalization
422.76M
31 days until earnings call
Interact to see
Advertisement

IOBT vs RGNX

Header iconIOBT vs RGNX Comparison
Open Charts IOBT vs RGNXBanner chart's image
IO Biotech
Price$1.44
Change-$0.07 (-4.64%)
Volume$145.1K
Capitalization94.87M
REGENXBIO
Price$8.39
Change-$0.36 (-4.11%)
Volume$1.19M
Capitalization422.76M
IOBT vs RGNX Comparison Chart in %
Loading...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IOBT vs. RGNX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOBT is a Buy and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (IOBT: $1.44 vs. RGNX: $8.39)
Brand notoriety: IOBT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOBT: 92% vs. RGNX: 103%
Market capitalization -- IOBT: $94.87M vs. RGNX: $422.76M
IOBT [@Biotechnology] is valued at $94.87M. RGNX’s [@Biotechnology] market capitalization is $422.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOBT’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • IOBT’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, IOBT is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOBT’s TA Score shows that 2 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • IOBT’s TA Score: 2 bullish, 6 bearish.
  • RGNX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than IOBT.

Price Growth

IOBT (@Biotechnology) experienced а +10.77% price change this week, while RGNX (@Biotechnology) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

IOBT is expected to report earnings on Aug 08, 2025.

RGNX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($423M) has a higher market cap than IOBT($94.9M). IOBT YTD gains are higher at: 56.522 vs. RGNX (8.538). IOBT has higher annual earnings (EBITDA): -96.7M vs. RGNX (-122.44M). RGNX has more cash in the bank: 268M vs. IOBT (37.1M). IOBT has less debt than RGNX: IOBT (1.76M) vs RGNX (79.8M). RGNX has higher revenues than IOBT: RGNX (157M) vs IOBT (0).
IOBTRGNXIOBT / RGNX
Capitalization94.9M423M22%
EBITDA-96.7M-122.44M79%
Gain YTD56.5228.538662%
P/E RatioN/AN/A-
Revenue0157M-
Total Cash37.1M268M14%
Total Debt1.76M79.8M2%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IOBTRGNX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 19 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BTRMF0.070.05
+245.00%
Battery Mineral Resources Corp.
BZLFY15.960.03
+0.19%
Bunzl plc
XCPT0.05N/A
N/A
XCana Petroleum Corp.
HLPMF8.90N/A
N/A
HELLENiQ ENERGY Holdings SA
BCCOY0.80N/A
N/A
BICO GROUP AB

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been loosely correlated with GLMD. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBT jumps, then GLMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
-2.70%
GLMD - IOBT
33%
Loosely correlated
+1.12%
DYN - IOBT
33%
Poorly correlated
-4.78%
RGNX - IOBT
30%
Poorly correlated
-4.11%
RNA - IOBT
29%
Poorly correlated
-2.68%
RAPT - IOBT
28%
Poorly correlated
-13.36%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with DNLI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-4.11%
DNLI - RGNX
58%
Loosely correlated
-2.69%
ARWR - RGNX
55%
Loosely correlated
+0.06%
BEAM - RGNX
53%
Loosely correlated
-1.98%
ARCT - RGNX
52%
Loosely correlated
-7.49%
VYGR - RGNX
51%
Loosely correlated
-0.34%
More